CV of project leader (Prof. Dr. Nicolas Singewald)

1977-1984 Studying Pharmacy at the University of Innsbruck
1989 Dr. rer. nat. (Pharmaceutical Chemistry)
1996 Associate Professor
1998-1999 Schroedinger Fellowship at the University of Oxford, UK, Department of Clinical Pharmacology, Prof. Grahame-Smith, Dr. Trevor Sharp
1999-2001

Interimistic head of the Department of Pharmacology and Toxicology University of Innsbruck

2002 Head of the Neuropharmacology unit at the Department of Pharmacology and Toxicology, LFU Innsbruck

 

Selected Publications

Salchner P, Sartori SB, Sinner C, Wigger A, Frank E, Landgraf R, Singewald N (2006) Airjet and FG-7142-induced Fos expression differs in rats selectively bred for high and low anxiety-related behavior. Neuropharmacology 50:1048-58

Keck ME, Sartori SB, Welt T, Muller MB, Ohl F, Holsboer F, Landgraf R, Singewald N (2005) Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment. J Neurochem 92:1170-1179.

Ebner K, Rupniak NM, Saria A, Singewald N (2004) Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats. Proc Natl Acad Sci U S A 101:4280-4285.

Salome N, Salchner P, Viltart O, Sequeira H, Wigger A, Landgraf R, Singewald N (2004) Neurobiological correlates of high (HAB) versus low anxiety-related behavior (LAB): differential Fos expression in HAB and LAB rats. Biol Psychiatry 55:715-723.

Singewald N, Salchner P, Sharp T (2003) Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs. Biol Psychiatry 53:275-283.